Initial Workup for Lymphadenopathy with Unplanned Weight Loss

History and Physical Examination Focus

• Evaluate for B symptoms, such as fever, night sweats, and unintentional weight loss, in patients with lymphadenopathy, as recommended by the National Comprehensive Cancer Network 1, 2

Laboratory Studies

• A complete blood count with differential should be performed to evaluate for cytopenias or abnormal cells, as suggested by the Journal of the National Comprehensive Cancer Network and Blood 3, 4
• Serum lactate dehydrogenase (LDH) should be measured as a potential marker for malignancy, according to the Journal of the National Comprehensive Cancer Network 3, 5
• Hepatitis B virus testing should be considered if immunotherapy or chemotherapy is being considered, as recommended by the Journal of the National Comprehensive Cancer Network and Journal of Hepatology 3, 6

Imaging Studies

• CT scans with contrast of chest, abdomen, and pelvis should be performed to evaluate the extent of lymphadenopathy and identify potential primary sites of malignancy, as suggested by the Journal of the National Comprehensive Cancer Network 5
• A PET-CT scan may be considered in selected cases, particularly when lymphoma is suspected, according to the Journal of the National Comprehensive Cancer Network and Praxis Medical Insights 1, 5

Tissue Diagnosis

• Excisional lymph node biopsy is the preferred diagnostic procedure for persistent unexplained lymphadenopathy, as recommended by Praxis Medical Insights 1
• Bone marrow biopsy should be considered, especially when blood counts are abnormal, as suggested by the Journal of the National Comprehensive Cancer Network and Blood 3, 4

Approach to Specific Lymphoma Types

• If Hairy Cell Leukemia is suspected, immunophenotyping should include specific markers, such as CD19, CD20, and CD103, as recommended by the Journal of the National Comprehensive Cancer Network 3
• For Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, evaluate peripheral blood for lymphocytosis and assess for hepatosplenomegaly, as suggested by Blood and the Journal of the National Comprehensive Cancer Network 2, 7
• For Mantle Cell Lymphoma, consider GI tract involvement, though routine endoscopy is not recommended unless clinically indicated, according to the Journal of the National Comprehensive Cancer Network 5

Initial Diagnostic Approach for Lymphadenopathy with Constitutional Symptoms

Diagnostic Tests

• The National Comprehensive Cancer Network recommends a peripheral blood film as the initial test for lymphadenopathy with constitutional symptoms, as it can rapidly identify lymphocytosis, abnormal lymphocytes, or circulating blasts that would indicate leukemia or lymphoma 8, 9, 10
• The blood film can establish the diagnosis of chronic lymphocytic leukemia (CLL) without requiring bone marrow examination initially, and can also detect acute leukemias with circulating blasts and lymphoma with peripheral blood involvement 8, 9, 11
• Excisional lymph node biopsy is the gold standard for definitive diagnosis when lymphoma is suspected, and should be pursued when the blood film shows abnormal lymphocytes requiring characterization, is non-diagnostic but clinical suspicion remains high, or when immunophenotyping and histologic architecture are needed for classification 12

Diagnostic Yield

• Bone marrow biopsy has a diagnostic yield of 23.7% in fever of unknown origin, particularly for hematologic malignancies, but is not the initial test in this scenario 12
• Bone marrow biopsy may be omitted in lymphoma staging if PET scan is negative or shows homogeneous uptake 12

Clinical Presentation

• The chronic nature (2 months) with B symptoms (fever, fatigue) suggests indolent lymphoma or CLL rather than acute leukemia 8, 11

Diagnostic Approach for Chronic Lymphadenopathy with Constitutional Symptoms

Initial Diagnostic Tests

• The American Society of Hematology recommends that a blood film alone can diagnose CLL when lymphocytosis exceeds 5 × 10⁹/L with characteristic small mature lymphocytes, eliminating the need for immediate bone marrow examination 13

Virology Screening Considerations

• The European Hematology Association suggests targeted virology screening, including EBV serology and PCR if post-transplant lymphoproliferative disorder or EBV-associated lymphoma is suspected, particularly in immunocompromised patients 14
• The American Association for the Study of Liver Diseases recommends CMV testing primarily in transplant recipients 15

Role of Bone Marrow Examination

• The American Society of Hematology recommends confirming complete remission in treated lymphoproliferative disorders through bone marrow biopsy, which requires <30% lymphocytes, normocellular morphology, and absence of lymphoid nodules 13

Bone Marrow Aspiration & Biopsy as the Definitive Diagnostic Test for Suspected Acute Lymphoblastic Leukemia in Children

Diagnostic Criteria for ALL

• The NCCN guidelines define acute lymphoblastic leukemia (ALL) by the presence of ≥ 20 % lymphoblasts in bone‑marrow aspirate/biopsy on hematopathology review. This threshold is required for a definitive diagnosis. 16

Recommended Initial Diagnostic Test

• In a child with generalized lymphadenopathy, hepatomegaly, low‑grade fever, and weight loss, the NCCN recommends bone‑marrow aspiration and biopsy as the first‑line diagnostic procedure because the presentation strongly suggests a marrow‑based malignancy rather than isolated lymphoma. 16

Role of Peripheral Blood Evaluation

• A complete blood count with differential and peripheral smear should be obtained, but peripheral blood alone is insufficient for diagnosis unless there is a very high white‑blood‑cell count accompanied by a significant proportion of circulating lymphoblasts, in which case the blood may substitute for marrow assessment. 16

When Lymph‑Node Biopsy Is Appropriate

• Excisional or incisional lymph‑node biopsy is the preferred initial test only when clinical features are more consistent with lymphoma (e.g., dominant lymphadenopathy with secondary organomegaly). The NCCN advises reserving node biopsy for cases where bone‑marrow results show < 20 % blasts yet lymphadenopathy persists. [17][18]

Practical Diagnostic Algorithm (per NCCN)

• Step 1 – Initial Blood Work: Obtain CBC, smear, LDH, and metabolic panel. If blood shows a very high white‑cell count with a substantial number of circulating lymphoblasts, a diagnosis of ALL may be established from blood alone. 16
• Step 2 – Bone‑Marrow Evaluation: If blood findings are abnormal, cytopenic, or otherwise suspicious, proceed directly to bone‑marrow aspiration/biopsy to achieve definitive diagnosis and enable comprehensive immunophenotyping, flow cytometry, and molecular/genetic risk stratification. 16
• Step 3 – Consider Node Biopsy: Perform lymph‑node biopsy only when marrow shows < 20 % blasts and clinical suspicion for lymphoma remains high. [16][17]18

Critical Pitfalls (NCCN Guidance)

• Do not delay bone‑marrow examination in favor of lymph‑node biopsy when hepatosplenomegaly and constitutional symptoms point toward leukemia. 16
• Do not rely solely on peripheral blood unless the criteria of very high white‑cell count with abundant circulating blasts are met; most ALL cases still require marrow confirmation. 16
• Avoid fine‑needle aspiration of lymph nodes as the initial diagnostic step for suspected lymphoma, as it provides insufficient tissue for accurate classification. [17][18]19

Bone Marrow Examination as the Confirmatory Test for Suspected Pediatric Acute Lymphoblastic Leukemia

Initial Diagnostic Approach

• The NCCN guidelines recommend bone marrow aspiration and biopsy as the first‑line investigation to confirm a diagnosis in a child with a 2‑month history of lethargy, pallor, low‑grade fever, and lymphadenopathy. 20
• If a complete blood count shows a markedly elevated white‑cell count with circulating blasts that meet the threshold of ≥1,000 blasts/µL or ≥20 % blasts, a diagnosis of ALL may be established from peripheral blood alone; otherwise, bone‑marrow sampling is required. 20

Bone Marrow Diagnostic Criteria

• Diagnosis of acute lymphoblastic leukemia requires ≥20 % lymphoblasts in the bone‑marrow aspirate/biopsy, which is the gold‑standard confirmatory threshold. [21][20]

Comprehensive Bone‑Marrow Evaluation

• The NCCN recommends that bone‑marrow assessment include morphology, cytochemistry, comprehensive immunophenotyping by flow cytometry, cytogenetic analysis (karyotyping and/or FISH), and molecular genetic studies to enable risk stratification and treatment planning. [21][22]

Limitations of Peripheral Blood Film Alone

• Peripheral blood smear is insufficient for definitive diagnosis unless the specific criteria of ≥1,000 circulating lymphoblasts/µL or ≥20 % blasts with overt disease are satisfied. 20
• Reliance solely on a blood film is discouraged even when blood counts appear near normal, because some children present with subtle hematologic abnormalities that evolve over time. 20

Staging Procedures

• A lumbar puncture to assess central‑nervous‑system involvement should be performed at diagnosis, provided there is no contraindication such as severe thrombocytopenia or coagulopathy. [21][23]
• Lymph‑node biopsy is reserved for cases where bone‑marrow analysis reveals <20 % blasts but clinical suspicion for lymphoma remains high. 20

Clinical Pitfalls to Avoid

• Do not delay bone‑marrow examination in favor of lymph‑node biopsy when constitutional symptoms and organomegaly suggest leukemia. 20
• Do not perform lumbar puncture in patients with severe thrombocytopenia or coagulopathy until the bleeding risk is corrected. 22